Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations
Journal of Clinical and Translational Pathology · 21.04.2023 · 000 (000) · 000-000
DOI: 10.14218/jctp.2023.00004 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Clinical and Translational Pathology, online erschienen am 21.04.2023. Verfasst von Tiannan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Over the past decades, cervical cancer has been a worldwide public health problem. Population-based early cancer risk detection and prevention approaches, including vaccination, cytology screening and human papilloma virus (HPV) detection, with the aligned clinical management, have formed a well-rounded high-quality implementation system for cervical cancer control, and revolutionarily improved the quality of life of women: (1) the success of cervical cancer screening practices, (2) standardization of The Bethesda system for reporting cervicovaginal cytology, (3) improvement in the understanding of HPV pathogenesis in cervical cancer, and (4) the development of appropriate management approaches have significantly decreased the disease burden of cervical cancer worldwide. This scoping review aimed to understand the evolvement of cervical cancer screening and management guidelines, describe the Bethesda cervical cytology reporting system, and HPV vaccines and tests, and highlight the key information of present policies and practices.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA.
- Department of Medicine, Department of Bioengineering, University of Pittsburgh Hillman Cancer Center, 5117 Centre Ave, Pittsburgh, PA, USA.
- Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
ORCID-Profile: Tiannan Wang, Chengquan Zhao
Förderung
- NCI NIH HHS
Zitieren
APA
Wang, T., Zhang, H., Liu, Y., & Zhao, C. (2023). Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations. Journal of Clinical and Translational Pathology, 000(000), 000-000. https://doi.org/10.14218/jctp.2023.00004
Vancouver
Wang T, Zhang H, Liu Y, Zhao C. Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations. Journal of Clinical and Translational Pathology. 2023;000(000):000-000. doi:10.14218/jctp.2023.00004
BibTeX
@article{Wang2023,
author = {Wang, Tiannan and Zhang, Huina and Liu, Yang and Zhao, Chengquan},
title = {Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations},
journal = {Journal of Clinical and Translational Pathology},
year = {2023},
volume = {000},
number = {000},
pages = {000--000},
doi = {10.14218/jctp.2023.00004}
}
EUVIMED